Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,738.22
(
0.58%
)
US TECH 100
24,202.40
(
0.78%
)
Dow Jones
47,172.44
(
0.48%
)
Brent Oil
98.98
(
0.69%
)
Bitcoin
74,867.42
(
0.03%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

turtlepower

Send PM Follow Ignore
Followers 1
Posts 1114
Boards Moderated 0
Alias Born 04/07/2009

turtlepower

Re: biomaven0 post# 96689

Thursday, 06/03/2010 9:36:46 PM

Thursday, June 03, 2010 9:36:46 PM

Post# of 257251
PYMX - Would the data from this small P1 trial be enough for a company selling LMWH to partner or do you think a PII trial would be required? I assume the surgery efficacy PII trial mentioned in the PR would include patients given Heparin and LMWH.

BTW I'm curious why "healthy subjects" would risk being injected with tinzaparin. I'm guessing the amount was harmless since there was the risk of 60056 not working.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now